11 hours ago
Some offers on this page are from advertisers who pay us, which may affect which products we write about, but not our recommendations. See our Advertiser Disclosure.
Gold doesn't rise or fall because of a single economic event. Its price reflects the decisions of millions of investors, central banks, manufacturers, jewelers, and others around the world. Those decisions are shaped by changing economic conditions and future expectations.
Understanding what drives the price of gold means learning how multiple forces interact. Sometimes they reinforce one another. Sometimes they pull in opposite directions. That's why different headlines can describe the same market move from different angles.
Every second the global gold market is open, buyers and sellers are negotiating a price — but they're not all buying gold for the same reason.
An investor may be looking to diversify a portfolio. A jewelry manufacturer may need gold for finished products. A technology company may use it in electronic components. A central bank may be increasing its reserves. Another investor may believe interest rates are about to fall.
#Gold #price #economic #different
Gold doesn't rise or fall because of a single economic event. Its price reflects the decisions of millions of investors, central banks, manufacturers, jewelers, and others around the world. Those decisions are shaped by changing economic conditions and future expectations.
Understanding what drives the price of gold means learning how multiple forces interact. Sometimes they reinforce one another. Sometimes they pull in opposite directions. That's why different headlines can describe the same market move from different angles.
Every second the global gold market is open, buyers and sellers are negotiating a price — but they're not all buying gold for the same reason.
An investor may be looking to diversify a portfolio. A jewelry manufacturer may need gold for finished products. A technology company may use it in electronic components. A central bank may be increasing its reserves. Another investor may believe interest rates are about to fall.
#Gold #price #economic #different
1 day ago
On September 8, 2026, GE Aerospace (NYSE:GE) agreed to buy Consolidated Precision Products (CPP) for $11.75 billion. The acquisition marks the company's largest bet yet on precision engine castings, a constraint that has been capping GE's growth. Trading already at roughly 40x earnings, the company has now attacked one of its genuine bottlenecks through the deal. But has it paid too much to do it?
Castings, including the superalloy and ******* anium hot-section parts inside the jet engines, have constrained GE's engine production, including programs such as LEAP and GEnx, as well as its high-margin aftermarket. Without these castings, the company can neither build nor service its engines. If the acquisition closes, the company will gain access to CPP's 20-plus plants and about 6,600 workers, which are essential for making those components. The deal would therefore enable GE to control the constraint as well as defend its margins. CEO Larry Culp characterized the move as securing manufacturing capacity to meet simultaneous demand across commercial engines, aftermarket services, and defense contracts.
The valuation is where bulls should slow down. GE is paying roughly 18x 2027 EBITDA including synergies (26x without synergies). The sellers are private equity firms Warburg Pincus and Berkshire Partners. They have basically offloaded a cyclical business near the peak of the aerospace cycle. This is smart money selling to GE instead of the other way around. The real tell is that GE felt compelled to buy its way past this capacity bottleneck instead of scaling organically, which reveals how tight its prized aftermarket really was. Also, CPP also supplies other major aerospace and defense companies such as Pratt & Whitney, Honeywell, and Lockheed Martin, and through the vertical tie-up, the company invites antitrust scrutiny before it closes in late 2027.
GE's 40x multiple rests on its high-margin razor-and-blade business model that services a huge installed base. And the casting supply shortages quietly constrain this aftermarket. Hence, more than merely fixing a supply chain issue, the CPP acquisition defends the company's high margin and multiple. Financially, the transaction is accretive to adjusted EPS and free cash flow in the first year, funded through $7 billion in cash alongside newly issued debt. Insider Monkey data shows 113 hedge funds held GE in Q2 2026, down modestly from 119 in Q1, reflecting firm institutional positioning. Short interest is just 1.3% of float, below peers like Honeywell International (1.6%). Almost no one bets against it.
#aftermarket #acquisition #including
Castings, including the superalloy and ******* anium hot-section parts inside the jet engines, have constrained GE's engine production, including programs such as LEAP and GEnx, as well as its high-margin aftermarket. Without these castings, the company can neither build nor service its engines. If the acquisition closes, the company will gain access to CPP's 20-plus plants and about 6,600 workers, which are essential for making those components. The deal would therefore enable GE to control the constraint as well as defend its margins. CEO Larry Culp characterized the move as securing manufacturing capacity to meet simultaneous demand across commercial engines, aftermarket services, and defense contracts.
The valuation is where bulls should slow down. GE is paying roughly 18x 2027 EBITDA including synergies (26x without synergies). The sellers are private equity firms Warburg Pincus and Berkshire Partners. They have basically offloaded a cyclical business near the peak of the aerospace cycle. This is smart money selling to GE instead of the other way around. The real tell is that GE felt compelled to buy its way past this capacity bottleneck instead of scaling organically, which reveals how tight its prized aftermarket really was. Also, CPP also supplies other major aerospace and defense companies such as Pratt & Whitney, Honeywell, and Lockheed Martin, and through the vertical tie-up, the company invites antitrust scrutiny before it closes in late 2027.
GE's 40x multiple rests on its high-margin razor-and-blade business model that services a huge installed base. And the casting supply shortages quietly constrain this aftermarket. Hence, more than merely fixing a supply chain issue, the CPP acquisition defends the company's high margin and multiple. Financially, the transaction is accretive to adjusted EPS and free cash flow in the first year, funded through $7 billion in cash alongside newly issued debt. Insider Monkey data shows 113 hedge funds held GE in Q2 2026, down modestly from 119 in Q1, reflecting firm institutional positioning. Short interest is just 1.3% of float, below peers like Honeywell International (1.6%). Almost no one bets against it.
#aftermarket #acquisition #including
1 day ago
Braze Inc. (NASDAQ:BRZE) turned in a strong second quarter. The reputed customer engagement platform showcased continued momentum across both its product strategy and financial performance. The company generated topline figure of $227.2 million, an impressive 26.2% increase compared to the same period last year. This revenue growth was fueled by upselling gains, customer additions and renewals. The company posted $24.2 million in cash flow from operating activities, a monumental growth relative to $7 million in the same period a year ago. This was paired with $21.7 million in free cash flow, against $3.5 million during Q2 FY26.
Jirsak/Shutterstock.com
The quarter brought several meaningful strategic moves. Braze broadened its BrazeAI Operator tool, which allows users to build new Canvas steps straight from conversational prompts. The company also signed a three-year Strategic Collaboration Agreement with AWS to support collaborative co-selling and go-to-market initiatives. The arrangement will incentivize AWS sellers for integrating Braze within their accounts.
For the latest quarter, subscription revenue jumped to $207.7 million from $171.8 million a year prior, while professional services and other revenue more than doubled, reaching $19.6 million. Dollar-based net retention among larger accounts, defined as those with annual recurring revenue of $500,000 or more, edged up to 112% in comparison to 111% a year earlier. Profitability metrics improved considerably as well, with adjusted operating income jumping to $22 million from $6 million, and adjusted diluted EPS increasing from $0.15 to $0.19.
Management cited growing demand for measurable return on investment as the primary force behind faster uptake of Braze's AI product lineup, which includes BrazeAI Operator, BrazeAI Agent Console, and BrazeAI Decisioning Studio.
#revenue
Jirsak/Shutterstock.com
The quarter brought several meaningful strategic moves. Braze broadened its BrazeAI Operator tool, which allows users to build new Canvas steps straight from conversational prompts. The company also signed a three-year Strategic Collaboration Agreement with AWS to support collaborative co-selling and go-to-market initiatives. The arrangement will incentivize AWS sellers for integrating Braze within their accounts.
For the latest quarter, subscription revenue jumped to $207.7 million from $171.8 million a year prior, while professional services and other revenue more than doubled, reaching $19.6 million. Dollar-based net retention among larger accounts, defined as those with annual recurring revenue of $500,000 or more, edged up to 112% in comparison to 111% a year earlier. Profitability metrics improved considerably as well, with adjusted operating income jumping to $22 million from $6 million, and adjusted diluted EPS increasing from $0.15 to $0.19.
Management cited growing demand for measurable return on investment as the primary force behind faster uptake of Braze's AI product lineup, which includes BrazeAI Operator, BrazeAI Agent Console, and BrazeAI Decisioning Studio.
#revenue
2 days ago
Arcosa, Inc. (NYSE:ACA) shareholders approved the proposed acquisition by CRH plc (NYSE:CRH) on September 4. The merger agreement received 39,595,867 votes in favor, compared with 66,113 against and 16,786 abstentions. Approximately 39.7 million shares, representing 80.8% of shares outstanding as of the record date, were present or represented by proxy.
The vote satisfies a major condition for the all-cash transaction. CRH plc (NYSE:CRH) agreed to pay $150 per share, valuing Arcosa, Inc. (NYSE:ACA) at an enterprise value of approximately $8.5 billion. The companies continue to expect a first-quarter 2027 closing, subject to required regulatory approvals and other customary conditions.
CRH plc (NYSE:CRH) described the valuation as 11.5 times estimated 2026 adjusted EBITDA, a company-defined non-GAAP measure, including $175 million of targeted annual run-rate cost synergies expected by year three. CRH plc (NYSE:CRH) defines adjusted EBITDA as earnings from continuing operations before interest, taxes, depreciation, depletion and amortization, with exclusions for impairments, divestitures and investments, equity-method results, substantial acquisition costs and specified pension items.
The result removes the principal seller-side approval risk. The merger no longer depends on another shareholder meeting, and support was decisive among the shares represented. Financing appears less exposed than regulatory clearance: CRH plc (NYSE:CRH) plans to use available cash and committed debt financing, while completion is not subject to a financing condition.
The strategic rationale is tangible. Arcosa, Inc. (NYSE:ACA) would add 109 quarries and yards, nine asphalt plants, 19 terminals and approximately 35 million tons of 2025 aggregates shipments. CRH plc (NYSE:CRH) expects more than 265 million tons of combined annualized aggregates production. Arcosa, Inc. (NYSE:ACA) also brings engineered structures serving grid modernization, electrification and data-center construction.
#NYSE #represented
The vote satisfies a major condition for the all-cash transaction. CRH plc (NYSE:CRH) agreed to pay $150 per share, valuing Arcosa, Inc. (NYSE:ACA) at an enterprise value of approximately $8.5 billion. The companies continue to expect a first-quarter 2027 closing, subject to required regulatory approvals and other customary conditions.
CRH plc (NYSE:CRH) described the valuation as 11.5 times estimated 2026 adjusted EBITDA, a company-defined non-GAAP measure, including $175 million of targeted annual run-rate cost synergies expected by year three. CRH plc (NYSE:CRH) defines adjusted EBITDA as earnings from continuing operations before interest, taxes, depreciation, depletion and amortization, with exclusions for impairments, divestitures and investments, equity-method results, substantial acquisition costs and specified pension items.
The result removes the principal seller-side approval risk. The merger no longer depends on another shareholder meeting, and support was decisive among the shares represented. Financing appears less exposed than regulatory clearance: CRH plc (NYSE:CRH) plans to use available cash and committed debt financing, while completion is not subject to a financing condition.
The strategic rationale is tangible. Arcosa, Inc. (NYSE:ACA) would add 109 quarries and yards, nine asphalt plants, 19 terminals and approximately 35 million tons of 2025 aggregates shipments. CRH plc (NYSE:CRH) expects more than 265 million tons of combined annualized aggregates production. Arcosa, Inc. (NYSE:ACA) also brings engineered structures serving grid modernization, electrification and data-center construction.
#NYSE #represented
0.00$ raised of 0.00$ goal
0 donations
0.00$
to go
2 days ago
Fear that rising oil prices will cascade into broader inflationary pressures brought sellers into Thursday's stock market ahead of a key reading on consumer price trends. Nvidia (NVDA) led blue chips lower after the artificial intelligence leader announced a new partnership with Palantir (PLTR).
Around midday Thursday, the Dow Jones Industrial Average fell 0.6% as the S&P 500 dropped 0.5%. The Nasdaq composite also gave back 0.5%. All three indexes are on track for their fourth consecutive day of declines. The small-cap Russell 2000 index moved down 0.8%.
West Texas Intermediate crude futures moved above $101 a barrel — a near-6% rise. Brent futures also rose nearly 6% to trade close to the $107 level.
The consumer price index report for August is due on Friday with estimates indicating price increases amounting to 0.4% month-on-month and 3.4% annually. Core inflation is seen ticking up 0.2% from July and 2.4% from August 2025.
The 10-year Treasury yield jumped nine basis points to 4.93%. Bitcoin fell to roughly $76,900.
#price #august
Around midday Thursday, the Dow Jones Industrial Average fell 0.6% as the S&P 500 dropped 0.5%. The Nasdaq composite also gave back 0.5%. All three indexes are on track for their fourth consecutive day of declines. The small-cap Russell 2000 index moved down 0.8%.
West Texas Intermediate crude futures moved above $101 a barrel — a near-6% rise. Brent futures also rose nearly 6% to trade close to the $107 level.
The consumer price index report for August is due on Friday with estimates indicating price increases amounting to 0.4% month-on-month and 3.4% annually. Core inflation is seen ticking up 0.2% from July and 2.4% from August 2025.
The 10-year Treasury yield jumped nine basis points to 4.93%. Bitcoin fell to roughly $76,900.
#price #august
0.00$ raised of 0.00$ goal
0 donations
0.00$
to go
4 days ago
Moerus Capital Management LLC, an investment management firm, recently released its "Worldwide Fund " second-quarter 2026 investor letter. A copy of the letter can be downloaded here. The fund navigated a highly bifurcated investment environment in the second quarter of 2026, as investor enthusiasm for artificial intelligence and technology drove a sharp rally in growth stocks while capital moved away from more traditional, value-oriented areas. The Fund's Institutional Class returned 0.14% in Q2, compared with 14.49% for the MSCI ACWI ex USA and 14.93% for the MSCI ACWI, while its first-half return stood at 5.37%, versus 13.69% and 11.25%, respectively, for the two benchmarks. The relative underperformance was primarily driven by the Fund's limited exposure to Information Technology as semiconductor and AI-related stocks surged, while its Energy holdings also gave back some earlier gains as oil prices declined; however, the Fund benefited from several energy-related investments during the first half. Looking ahead, Moerus views the extreme gap between expensive AI-focused areas and neglected parts of the market as an opportunity, maintaining its long-term deep-value approach of investing in unpopular businesses and ****** ets at significant discounts to intrinsic value and using market volatility to identify potentially attractive investments. In addition, please check the Fund's top five holdings to know its best picks in 2026.
In its second-quarter 2026 investor letter, Moerus Worldwide Fund highlighted stocks like Tidewater Inc. (NYSE:TDW). Tidewater Inc. is an offshore supply vessel operator that provides support services to the offshore energy industry. Moerus identified Tidewater as one of the Fund's five most significant positive contributors during the first half of 2026. The one-month return of Tidewater Inc. (NYSE:TDW) was 3.68% while its shares traded between $46.65 and $101.58 over the last 52 weeks. On September 7, 2026, Tidewater Inc. (NYSE:TDW) stock closed at approximately $94.26 per share, with a market capitalization of about $4.61 billion.
Moerus Worldwide Fund stated the following regarding Tidewater Inc. (NYSE:TDW) in its Q2 2026 investor letter:
"Similarly, we'd argue that offshore supply vessel (OSV) operator Tidewater Inc. (NYSE:TDW) has grown the per share value of its business dramatically since 2018 through a combination of a relentless focus on costs, share repurchases, and most notably, the utilization of its OSV industry-leading balance sheet to make three acquisitions of ****** ets (with a fourth pending) from distressed and/or motivated sellers at deep discounts to replacement costs during a years-long industry depression."
#tidewater #fund #energy #second
In its second-quarter 2026 investor letter, Moerus Worldwide Fund highlighted stocks like Tidewater Inc. (NYSE:TDW). Tidewater Inc. is an offshore supply vessel operator that provides support services to the offshore energy industry. Moerus identified Tidewater as one of the Fund's five most significant positive contributors during the first half of 2026. The one-month return of Tidewater Inc. (NYSE:TDW) was 3.68% while its shares traded between $46.65 and $101.58 over the last 52 weeks. On September 7, 2026, Tidewater Inc. (NYSE:TDW) stock closed at approximately $94.26 per share, with a market capitalization of about $4.61 billion.
Moerus Worldwide Fund stated the following regarding Tidewater Inc. (NYSE:TDW) in its Q2 2026 investor letter:
"Similarly, we'd argue that offshore supply vessel (OSV) operator Tidewater Inc. (NYSE:TDW) has grown the per share value of its business dramatically since 2018 through a combination of a relentless focus on costs, share repurchases, and most notably, the utilization of its OSV industry-leading balance sheet to make three acquisitions of ****** ets (with a fourth pending) from distressed and/or motivated sellers at deep discounts to replacement costs during a years-long industry depression."
#tidewater #fund #energy #second
7 days ago
A large land-sale gain can push Medicare Part B premiums from $203 to $690 monthly, with the IRMAA impact arriving two years after closing.
Federal installment-sale rules let sellers spread gain recognition across multiple years, softening Medicare surcharges and Social Security tax exposure.
Taking the full lump sum eliminates buyer default risk, but installment sales may only reduce years spent at peak IRMAA tiers, not avoid them entirely.
Just released. Our ***** ysts combed the entire stock market and named the ten best stocks to buy right now. The report is free. Enter your email and see if any of your stocks made the cut.
A retired man in his late sixties owns rural land that suddenly sits in the path of a data center developer. The offer runs into seven figures. He is ready to sell, but instead of taking every dollar at closing, he negotiates payments over several years.
#irmaa #gain
Federal installment-sale rules let sellers spread gain recognition across multiple years, softening Medicare surcharges and Social Security tax exposure.
Taking the full lump sum eliminates buyer default risk, but installment sales may only reduce years spent at peak IRMAA tiers, not avoid them entirely.
Just released. Our ***** ysts combed the entire stock market and named the ten best stocks to buy right now. The report is free. Enter your email and see if any of your stocks made the cut.
A retired man in his late sixties owns rural land that suddenly sits in the path of a data center developer. The offer runs into seven figures. He is ready to sell, but instead of taking every dollar at closing, he negotiates payments over several years.
#irmaa #gain
7 days ago
Palantir Technologies' stock jumped approximately 8% on Thursday, recovering from the previous session's nearly 6% decline and trading near $183.
The rebound came even as prominent short-seller Michael Burry, known for his role in "The Big Short," renewed his long-standing bearish critique of the company.
In a detailed post on X early Thursday, Burry reiterated that Palantir is back in the stratosphere and that the facts have not changed. He described the firm as a consultant riding a bubble of AI FOMO demand and warned that its market cap could eventually fall well below $100 billion.
Burry focused on accounts receivable trends, noting that receivables had grown faster than revenue in 9 of the last 12 quarters, with one customer accounting for about 25% of receivables while contributing less than 10% of revenue.
He also highlighted rising days sales outstanding, deferred revenue patterns resembling those of consulting firms like Accenture rather than pure SaaS peers, elevated stock-based compensation, and large net operating losses. Burry disclosed that he remains short the stock and holds put options.
#Stock #revenue
The rebound came even as prominent short-seller Michael Burry, known for his role in "The Big Short," renewed his long-standing bearish critique of the company.
In a detailed post on X early Thursday, Burry reiterated that Palantir is back in the stratosphere and that the facts have not changed. He described the firm as a consultant riding a bubble of AI FOMO demand and warned that its market cap could eventually fall well below $100 billion.
Burry focused on accounts receivable trends, noting that receivables had grown faster than revenue in 9 of the last 12 quarters, with one customer accounting for about 25% of receivables while contributing less than 10% of revenue.
He also highlighted rising days sales outstanding, deferred revenue patterns resembling those of consulting firms like Accenture rather than pure SaaS peers, elevated stock-based compensation, and large net operating losses. Burry disclosed that he remains short the stock and holds put options.
#Stock #revenue
8 days ago
The crypto market—including Bitcoin and altcoins like XRP, Ethereum, and BNB—is riding a bullish wave of momentum in the U.S. stock market, seemingly triggered by fresh comments from the Federal Reserve, and sending short sellers to goblintown.
Bitcoin punched back above $80,000 on Thursday, trading near $80,270 and up close to 3% over the past 24 hours. Ethereum is closing in on $2,500, up 2.2% today, while XRP is up a whopping 6% in the last 24 hours. The spike has accounted for at least $327 million in liquidated short positions in the last hour alone, and more than $415 million in the past 24 hours.
The catalyst appears to be comments from Fed Governor Christopher Waller, who, in prepared remarks at a Reuters NEXT Newsmaker interview, said he'd be "inclined to support" holding the Fed's benchmark interest rate at its current level if upcoming inflation data keeps improving.
Traders took the hint. The odds of a rate hike at the Fed's September 15-16 meeting fell to 50.4%, down from 63.2% a day earlier, according to the CME FedWatch tool, a market gauge that estimates the odds of Fed moves from futures prices. The 10-year Treasury yield, a benchmark for borrowing costs economy-wide that had touched its highest level since November 2023 a day earlier, dropped to around 4.73%.
It's a sharp reversal from a week ago. Fed Chair Kevin Warsh's hawkish Jackson Hole keynote had knocked Bitcoin down to $76,877 and pushed hike odds toward 56%. Thursday's bounce puts Bitcoin back at a level it's tested—and failed to hold—several times this year.
#short #back
Bitcoin punched back above $80,000 on Thursday, trading near $80,270 and up close to 3% over the past 24 hours. Ethereum is closing in on $2,500, up 2.2% today, while XRP is up a whopping 6% in the last 24 hours. The spike has accounted for at least $327 million in liquidated short positions in the last hour alone, and more than $415 million in the past 24 hours.
The catalyst appears to be comments from Fed Governor Christopher Waller, who, in prepared remarks at a Reuters NEXT Newsmaker interview, said he'd be "inclined to support" holding the Fed's benchmark interest rate at its current level if upcoming inflation data keeps improving.
Traders took the hint. The odds of a rate hike at the Fed's September 15-16 meeting fell to 50.4%, down from 63.2% a day earlier, according to the CME FedWatch tool, a market gauge that estimates the odds of Fed moves from futures prices. The 10-year Treasury yield, a benchmark for borrowing costs economy-wide that had touched its highest level since November 2023 a day earlier, dropped to around 4.73%.
It's a sharp reversal from a week ago. Fed Chair Kevin Warsh's hawkish Jackson Hole keynote had knocked Bitcoin down to $76,877 and pushed hike odds toward 56%. Thursday's bounce puts Bitcoin back at a level it's tested—and failed to hold—several times this year.
#short #back
8 days ago
Kala Bio, Inc. (NASDAQ:KALA) and Virotek Inc. have finalised an exclusive distribution and reseller agreement covering Virotek's ophthalmology genomic testing and screening programme in the United States.
Under the agreement, which took effect on September 4, 2026, Kala will serve as the sole U.S. distributor of the programme and will have the right to market, promote, distribute and resell Virotek's ophthalmology genetic testing services.
The agreement has an initial one-year term, with continued exclusivity dependent on Kala achieving agreed commercial milestones. It follows a non-binding letter of intent announced on September 1, 2026.
Virotek will remain responsible for the programme's infrastructure, supply of testing kits, specimen processing and clinical reporting. The company will also provide training and supporting materials to Kala's channel partners.
The companies have agreed to a profit-sharing arrangement that will take effect after Virotek recovers its programme costs. No additional financial terms were disclosed.
#programme
Under the agreement, which took effect on September 4, 2026, Kala will serve as the sole U.S. distributor of the programme and will have the right to market, promote, distribute and resell Virotek's ophthalmology genetic testing services.
The agreement has an initial one-year term, with continued exclusivity dependent on Kala achieving agreed commercial milestones. It follows a non-binding letter of intent announced on September 1, 2026.
Virotek will remain responsible for the programme's infrastructure, supply of testing kits, specimen processing and clinical reporting. The company will also provide training and supporting materials to Kala's channel partners.
The companies have agreed to a profit-sharing arrangement that will take effect after Virotek recovers its programme costs. No additional financial terms were disclosed.
#programme
8 days ago
Gold bulls came roaring back in August.
Then sellers showed up right on cue and pushed prices back toward a level buyers were waiting for.
Gold (GC=F) has been trading around one of technical ******* ysis's simplest ideas: the halfway-back mark. After a big move, traders often wait for the price to retrace 50%, because that's where the risk-reward can suddenly get attractive — you can enter near the level and get out quickly if it doesn't hold.
Start with gold's big downswing this year.
Gold futures (GC=F) closed at 5,508.6 on Jan. 29 (1 on the chart below), then fell to 4,048.7 by July 16 (2). The halfway-back level between those two points was 4,778.7, marked by the red dotted line near (3).
#Gold #Bulls
Then sellers showed up right on cue and pushed prices back toward a level buyers were waiting for.
Gold (GC=F) has been trading around one of technical ******* ysis's simplest ideas: the halfway-back mark. After a big move, traders often wait for the price to retrace 50%, because that's where the risk-reward can suddenly get attractive — you can enter near the level and get out quickly if it doesn't hold.
Start with gold's big downswing this year.
Gold futures (GC=F) closed at 5,508.6 on Jan. 29 (1 on the chart below), then fell to 4,048.7 by July 16 (2). The halfway-back level between those two points was 4,778.7, marked by the red dotted line near (3).
#Gold #Bulls
8 days ago
Billionaire Stanley Druckenmiller made two very different-looking AI purchases in the second quarter that share one underlying thesis. Duquesne Family Office increased its Amazon.com, Inc. (NASDAQ:AMZN) position by 1,083% to 541,600 shares and opened a 72,900-share stake in Advanced Micro Devices, Inc. (NASDAQ:AMD). One company rents computing capacity through AWS; the other supplies accelerators and server processors. Together, the positions give Duquesne exposure to an AI infrastructure platform and a credible alternative chip supplier, although the filing does not disclose Druckenmiller's rationale.
Amazon.com, Inc. (NASDAQ:AMZN) offers the demand platform. AWS revenue grew 36.7% in the second quarter, while Amazon's capital-spending trajectory approached roughly $220 billion. The bull case is that its cloud customer relationships, custom silicon, and enormous infrastructure base let it capture AI usage across models and chips. The bear case is that depreciation, power, and construction costs arrive before utilization. Even strong cloud growth must eventually produce returns on a spending program larger than many national economies.
Advanced Micro Devices, Inc. (NASDAQ:AMD) offers more direct operating leverage. Its data-center revenue more than doubled, and customers want an alternative to Nvidia for accelerators and CPUs. If AMD's software improves and hyperscalers deploy Instinct at scale, revenue can grow faster than the broader infrastructure market. Yet it must compete against an entrenched platform while also funding an aggressive roadmap. A second-source narrative is valuable, but only sustained deployments turn it into durable margins.
The common exposure works because Amazon can profit from rising AI consumption regardless of which merchant chip gains share, while AMD can benefit if that consumption creates room for multiple suppliers. The risks also interact. Amazon's own chips could limit AMD's opportunity, and slower cloud utilization would pressure both the buyer of infrastructure and the seller of processors. Both positions could benefit if the market grows faster than those internal conflicts.
Hedge funds moved in the same direction. Amazon ownership rose to 369 funds in the second quarter from 353, while AMD ownership jumped to 164 from 134. Arrowstreet Capital increased its Amazon position 24% to 40.3 million shares, and Marshall Wace raised its AMD common-share stake 3% to 3.9 million shares. As of August 14, 40.1 million AMD shares were sold short, equal to 2.47% of the float and 1.5 days of trading volume. The modest short-interest snapshot shows limited reported short positioning in AMD; it does not resolve whether AMD can capture enough of the spending Amazon is helping unleash.
#amazon #shares
Amazon.com, Inc. (NASDAQ:AMZN) offers the demand platform. AWS revenue grew 36.7% in the second quarter, while Amazon's capital-spending trajectory approached roughly $220 billion. The bull case is that its cloud customer relationships, custom silicon, and enormous infrastructure base let it capture AI usage across models and chips. The bear case is that depreciation, power, and construction costs arrive before utilization. Even strong cloud growth must eventually produce returns on a spending program larger than many national economies.
Advanced Micro Devices, Inc. (NASDAQ:AMD) offers more direct operating leverage. Its data-center revenue more than doubled, and customers want an alternative to Nvidia for accelerators and CPUs. If AMD's software improves and hyperscalers deploy Instinct at scale, revenue can grow faster than the broader infrastructure market. Yet it must compete against an entrenched platform while also funding an aggressive roadmap. A second-source narrative is valuable, but only sustained deployments turn it into durable margins.
The common exposure works because Amazon can profit from rising AI consumption regardless of which merchant chip gains share, while AMD can benefit if that consumption creates room for multiple suppliers. The risks also interact. Amazon's own chips could limit AMD's opportunity, and slower cloud utilization would pressure both the buyer of infrastructure and the seller of processors. Both positions could benefit if the market grows faster than those internal conflicts.
Hedge funds moved in the same direction. Amazon ownership rose to 369 funds in the second quarter from 353, while AMD ownership jumped to 164 from 134. Arrowstreet Capital increased its Amazon position 24% to 40.3 million shares, and Marshall Wace raised its AMD common-share stake 3% to 3.9 million shares. As of August 14, 40.1 million AMD shares were sold short, equal to 2.47% of the float and 1.5 days of trading volume. The modest short-interest snapshot shows limited reported short positioning in AMD; it does not resolve whether AMD can capture enough of the spending Amazon is helping unleash.
#amazon #shares
8 days ago
Some offers on this page are from advertisers who pay us, which may affect which products we write about, but not our recommendations. See our Advertiser Disclosure.
A housing market crash happens when home values plummet due to a lack of demand for or an oversupply of homes. The factors leading to a housing market crash are varied, ranging from economic recessions to high mortgage rates that make it less affordable to buy a home. A housing crash can have upsides (low home prices) and downsides (losing built-up equity and tighter finances).
So, what's ahead for the housing market in 2026?
Read more: Want to buy a house in 2026? Here's what you need to know.
Despite 58% of Gen Z wanting a housing market crash, according to Clever, experts don't foresee one in 2026. If anything, they see a greater sense of normalcy following multiple years of twists and turns.
"We're not heading toward a housing crash; we're in a market correction defined by stability, not volatility," Hoby Hanna, CEO of Howard Hanna Real Estate Services, said via email. "Today's housing environment is fundamentally different from 2008. Homeowners have record levels of equity, lending standards are sound, and inventory remains constrained. What we're seeing now is a normalization, not a collapse, as the market adjusts to new economic realities. For buyers and sellers, this is a market filled with opportunity and resilience, not instability or uncertainty."
#we 're #hanna #Equity #disclosure
A housing market crash happens when home values plummet due to a lack of demand for or an oversupply of homes. The factors leading to a housing market crash are varied, ranging from economic recessions to high mortgage rates that make it less affordable to buy a home. A housing crash can have upsides (low home prices) and downsides (losing built-up equity and tighter finances).
So, what's ahead for the housing market in 2026?
Read more: Want to buy a house in 2026? Here's what you need to know.
Despite 58% of Gen Z wanting a housing market crash, according to Clever, experts don't foresee one in 2026. If anything, they see a greater sense of normalcy following multiple years of twists and turns.
"We're not heading toward a housing crash; we're in a market correction defined by stability, not volatility," Hoby Hanna, CEO of Howard Hanna Real Estate Services, said via email. "Today's housing environment is fundamentally different from 2008. Homeowners have record levels of equity, lending standards are sound, and inventory remains constrained. What we're seeing now is a normalization, not a collapse, as the market adjusts to new economic realities. For buyers and sellers, this is a market filled with opportunity and resilience, not instability or uncertainty."
#we 're #hanna #Equity #disclosure
8 days ago
The secondhand apparel market is booming, and financial experts say there's real money to be made both as a savvy shopper and a seller. According to a new report from ThredUp, the U.S. secondhand market has exploded from roughly $28 billion in 2020 to approximately $56 billion today, with 62% of Gen Z participating in secondhand shopping last year.
But while the opportunity is real, so is the potential to turn a financial win into a spending trap. We asked finance experts for their best approaches to capitalize on this trend without letting low prices trick you into mindless spending.
Before committing to a regular thrift habit, you need to find a place where you actually enjoy shopping. Not every platform or store will feel right, and that's fine.
As Melanie Musson, a finance expert with Quote.com, explained, "If you walk into a massive Goodwill store, you may feel overwhelmed and have a strong desire to leave. That's okay. If you walk into a local hospital boost club thrift store, and it's so tiny with low ceilings and you feel closed in, it's okay to leave. However, if you love the experience, embrace it."
Musson recommended checking out at least five different stores or platforms to find what works for you.
#store #Experts
But while the opportunity is real, so is the potential to turn a financial win into a spending trap. We asked finance experts for their best approaches to capitalize on this trend without letting low prices trick you into mindless spending.
Before committing to a regular thrift habit, you need to find a place where you actually enjoy shopping. Not every platform or store will feel right, and that's fine.
As Melanie Musson, a finance expert with Quote.com, explained, "If you walk into a massive Goodwill store, you may feel overwhelmed and have a strong desire to leave. That's okay. If you walk into a local hospital boost club thrift store, and it's so tiny with low ceilings and you feel closed in, it's okay to leave. However, if you love the experience, embrace it."
Musson recommended checking out at least five different stores or platforms to find what works for you.
#store #Experts
8 days ago
During the August 31 episode of Mad Money, Jim Cramer examined the sharp rotation back into enterprise software following the forced unwinding of bearish hedge fund positions. Mentioning Veeva Systems Inc. (NYSE:VEEV) and Salesforce, Inc. (NYSE:CRM) as examples of sector leaders, he commented:
Situational Awareness just despised enterprise software and Veeva Systems, number three, up 40%, is enterprise software writ large for the healthcare industry. I think it's bounced back in conjunction with all the other enterprise software companies that Situational Awareness believed would be destroyed by AI that haven't been. Once that hedge fund blew up, the whole group came roaring back as Situational was no longer there to put pressure on them. Hey, Salesforce had a similar rally, up nearly 40%. Now, here's one that openly took on the short sellers first with rhetoric and then with numbers which have not been hurt at all by… the SaaS-pocalypse. His blowout quarter obliterated the shorts. I don't think they still know what hit them.
For months, bearish macro funds aggressively shorted enterprise software providers, on the belief that emerging artificial intelligence platforms would easily replicate proprietary workflows and trigger severe pricing compression.
Salesforce, Inc. (NYSE:CRM) and Veeva Systems Inc. (NYSE:VEEV) proved the exact opposite. Salesforce showed that autonomous enterprise features act as expansion engines. Similarly, Veeva Systems, which powers critical clinical and commercial operations for the heavily regulated life sciences sector, integrated advanced data capabilities directly into its platform. Rather than cannibalizing software licenses, artificial intelligence features reinforced the massive switching costs embedded in both platforms.
Despite solid execution, market skeptics continue to scrutinize the growth limits and valuation multiples of both companies. Salesforce, Inc. (NYSE:CRM) trades at a forward P/E of 19x, showing market hesitation over macroeconomic budget tightening and the necessity for the company to rapidly monetize its heavy artificial intelligence investments.
#salesforce #situational #artificial #intelligence
Situational Awareness just despised enterprise software and Veeva Systems, number three, up 40%, is enterprise software writ large for the healthcare industry. I think it's bounced back in conjunction with all the other enterprise software companies that Situational Awareness believed would be destroyed by AI that haven't been. Once that hedge fund blew up, the whole group came roaring back as Situational was no longer there to put pressure on them. Hey, Salesforce had a similar rally, up nearly 40%. Now, here's one that openly took on the short sellers first with rhetoric and then with numbers which have not been hurt at all by… the SaaS-pocalypse. His blowout quarter obliterated the shorts. I don't think they still know what hit them.
For months, bearish macro funds aggressively shorted enterprise software providers, on the belief that emerging artificial intelligence platforms would easily replicate proprietary workflows and trigger severe pricing compression.
Salesforce, Inc. (NYSE:CRM) and Veeva Systems Inc. (NYSE:VEEV) proved the exact opposite. Salesforce showed that autonomous enterprise features act as expansion engines. Similarly, Veeva Systems, which powers critical clinical and commercial operations for the heavily regulated life sciences sector, integrated advanced data capabilities directly into its platform. Rather than cannibalizing software licenses, artificial intelligence features reinforced the massive switching costs embedded in both platforms.
Despite solid execution, market skeptics continue to scrutinize the growth limits and valuation multiples of both companies. Salesforce, Inc. (NYSE:CRM) trades at a forward P/E of 19x, showing market hesitation over macroeconomic budget tightening and the necessity for the company to rapidly monetize its heavy artificial intelligence investments.
#salesforce #situational #artificial #intelligence
9 days ago
On August 26, Biohaven (NYSE:BHVN) and SK Biopharmaceuticals announced a global licensing agreement covering opakalim, Biohaven's lead epilepsy candidate, in a deal worth up to $795 million plus royalties. SK Biopharmaceuticals picks up exclusive worldwide rights to Biohaven's Kv7 ion channel platform, while Biohaven walks away with $400 million in near-term cash. The timing lines up with an August 10, 2026 earnings report that showed Biohaven still losing well over $100 million a quarter, and the gap between those two dates explains a lot about why this deal happened now.
SK Biopharmaceuticals will pay up to $795 million in upfront and milestone payments connected to the Kv7 platform, on top of tiered royalties on US net sales of opakalim that range from the mid-teens to low twenties. Biohaven collects $350 million at closing and another $50 million in 2027, with as much as $150 million more available through development and regulatory milestones plus royalties on global sales. SK Biopharmaceuticals is also taking over Kv7 program costs going forward, including certain Knopp Biosciences obligations. CEO Vlad Coric described the structure as proof Biohaven can monetize its pipeline through partnerships rather than leaning on public markets for cash.
The deal only makes sense because opakalim looks like it works. In a proof-of-concept study in idiopathic generalized epilepsy, the median time to a second generalized tonic-clonic seizure stretched to 141 days on opakalim versus 47 days on placebo, and a third of patients made it through the full 24 weeks without a second seizure. In focal epilepsy, 54% of patients in an open-label extension study saw at least a 50% drop in seizure frequency over any six months, in a group of more than 100 patients.
Opakalim is also designed as a once-daily pill with no ******* ration required, a real edge over older antiseizure drugs. Pairing that data with SK Biopharmaceuticals, the company behind XCOPRI and the only firm to bring a new focal-seizure drug to the US market since 2016, gives Opakalim a commercial path Biohaven would have struggled to build alone. The cash also buys runway for the rest of the pipeline, including protein degraders BHV-1300 and BHV-1400, which have shown rapid, selective reductions in disease-driving antibodies in Graves' disease and IgA nephropathy with clean safety data across nearly 200 patients dosed.
Biohaven is giving up full ownership of an ******* et it now believes could be a major seller. Royalties in the mid-teens to low twenties are real money, but they are a fraction of what outright ownership of an approved epilepsy drug would be worth, and $50 million of the $400 million upfront does not arrive until 2027. The Knopp Biosciences obligations SK Biopharmaceuticals is absorbing, worth up to $245 million plus mid-single-digit royalties, are a reminder that other parties already have claims on opakalim's future revenue before Biohaven sees a dollar of profit from it.
#ro
SK Biopharmaceuticals will pay up to $795 million in upfront and milestone payments connected to the Kv7 platform, on top of tiered royalties on US net sales of opakalim that range from the mid-teens to low twenties. Biohaven collects $350 million at closing and another $50 million in 2027, with as much as $150 million more available through development and regulatory milestones plus royalties on global sales. SK Biopharmaceuticals is also taking over Kv7 program costs going forward, including certain Knopp Biosciences obligations. CEO Vlad Coric described the structure as proof Biohaven can monetize its pipeline through partnerships rather than leaning on public markets for cash.
The deal only makes sense because opakalim looks like it works. In a proof-of-concept study in idiopathic generalized epilepsy, the median time to a second generalized tonic-clonic seizure stretched to 141 days on opakalim versus 47 days on placebo, and a third of patients made it through the full 24 weeks without a second seizure. In focal epilepsy, 54% of patients in an open-label extension study saw at least a 50% drop in seizure frequency over any six months, in a group of more than 100 patients.
Opakalim is also designed as a once-daily pill with no ******* ration required, a real edge over older antiseizure drugs. Pairing that data with SK Biopharmaceuticals, the company behind XCOPRI and the only firm to bring a new focal-seizure drug to the US market since 2016, gives Opakalim a commercial path Biohaven would have struggled to build alone. The cash also buys runway for the rest of the pipeline, including protein degraders BHV-1300 and BHV-1400, which have shown rapid, selective reductions in disease-driving antibodies in Graves' disease and IgA nephropathy with clean safety data across nearly 200 patients dosed.
Biohaven is giving up full ownership of an ******* et it now believes could be a major seller. Royalties in the mid-teens to low twenties are real money, but they are a fraction of what outright ownership of an approved epilepsy drug would be worth, and $50 million of the $400 million upfront does not arrive until 2027. The Knopp Biosciences obligations SK Biopharmaceuticals is absorbing, worth up to $245 million plus mid-single-digit royalties, are a reminder that other parties already have claims on opakalim's future revenue before Biohaven sees a dollar of profit from it.
#ro
9 days ago
Selling an inherited rental home triggers a large taxable gain since depreciation reduces basis and the Section 121 home-sale exclusion doesn't apply.
IRMAA uses income from two years prior, so a large 2026 gain can push both spouses into Medicare's $649 monthly Part B tier by 2028.
A voluntary property sale disqualifies sellers from SSA-44 relief, but IRMAA resets annually, so higher premiums should last only one affected year.
Read More: Learn 7 ways to generate income with a $1,000,000+ portfolio (sponsor)
A 68-year-old retiree in Ohio inherited his parents' three-bedroom colonial when his mother died in 2006. He never moved in. Instead, he rented it for 20 years before selling it this spring for a price that felt like a lottery win. He and his wife are both on Medicare. What they may not realize is that the sale can come back two years later in the form of substantially higher premiums.
#selling #inherited #home #large
IRMAA uses income from two years prior, so a large 2026 gain can push both spouses into Medicare's $649 monthly Part B tier by 2028.
A voluntary property sale disqualifies sellers from SSA-44 relief, but IRMAA resets annually, so higher premiums should last only one affected year.
Read More: Learn 7 ways to generate income with a $1,000,000+ portfolio (sponsor)
A 68-year-old retiree in Ohio inherited his parents' three-bedroom colonial when his mother died in 2006. He never moved in. Instead, he rented it for 20 years before selling it this spring for a price that felt like a lottery win. He and his wife are both on Medicare. What they may not realize is that the sale can come back two years later in the form of substantially higher premiums.
#selling #inherited #home #large
10 days ago
COLUMBIA — South Carolina football is ready to take the field for the first time in 39 weeks.
The Gamecocks begin Year 6 with coach Shane Beamer on Sept. 5 against Kent State. Kickoff is set for 12:45 p.m. ET (SEC Network) in Williams-Brice Stadium.
South Carolina is coming off a 4-8 season but returns a trio of stars in starting quarterback LaNorris Sellers, edge rusher Dylan Stewart and wide receiver Nyck Harbor, along with 25 new transfers.
Tickets for the game are still available for purchase. Here's where to buy tickets.
Buy South Carolina football tickets on StubHub
#beamer
The Gamecocks begin Year 6 with coach Shane Beamer on Sept. 5 against Kent State. Kickoff is set for 12:45 p.m. ET (SEC Network) in Williams-Brice Stadium.
South Carolina is coming off a 4-8 season but returns a trio of stars in starting quarterback LaNorris Sellers, edge rusher Dylan Stewart and wide receiver Nyck Harbor, along with 25 new transfers.
Tickets for the game are still available for purchase. Here's where to buy tickets.
Buy South Carolina football tickets on StubHub
#beamer
10 days ago
ShipStation, a provider of multicarrier parcel shipping software, is offering e-commerce sellers the ability to also select and coordinate with less-than-truckload operators at pre-negotiated rates in one integrated platform, bringing to life promised benefits from ownership's recent acquisition of freight brokerage Worldwide Express Group.
Few, if any, software-as-a-service companies that connect small-and-midsize merchants with parcel carriers offer a pallet-shipping solution.
"Most of those small companies don't have enough volumes to do full truckload so their first need after parcel shipping tends to be LTL, which creates this natural linkage between LTL freight brokerage and parcel," said Chris Wofford, the founder of Wofford Advisors LLC, a strategic advisory firm for the logistics sector.
In early June, private equity firm Thoma Bravo acquired WWEX Group and merged it with portfolio company Auctane, which provides shipping and fulfillment technology through brands like ShipStation, Stamps.com, Metapack and Packlink. The combined valuation of the companies is $12 billion.
WWEX Group companies include Worldwide Express, GlobalTranz, Unishippers, JEAR Logistics and BLX Logistics.
#group #Logistics
Few, if any, software-as-a-service companies that connect small-and-midsize merchants with parcel carriers offer a pallet-shipping solution.
"Most of those small companies don't have enough volumes to do full truckload so their first need after parcel shipping tends to be LTL, which creates this natural linkage between LTL freight brokerage and parcel," said Chris Wofford, the founder of Wofford Advisors LLC, a strategic advisory firm for the logistics sector.
In early June, private equity firm Thoma Bravo acquired WWEX Group and merged it with portfolio company Auctane, which provides shipping and fulfillment technology through brands like ShipStation, Stamps.com, Metapack and Packlink. The combined valuation of the companies is $12 billion.
WWEX Group companies include Worldwide Express, GlobalTranz, Unishippers, JEAR Logistics and BLX Logistics.
#group #Logistics
10 days ago
The U.S. Federal Trade Commission, joined by 22 states, has sued Amazon.com, Inc. (NASDAQ:AMZN) over allegations that the company secretly inflated prices in its advertising auctions for more than seven years. The FTC alleges that Amazon used an undisclosed "soft reserve price" to raise the amount advertisers paid above what competitive bidding would have produced.
According to the complaint, the practice affected more than one million brands and sellers and may have generated tens of billions of dollars in additional revenue for Amazon. The FTC also alleges that the pricing changes became increasingly aggressive, with advertisers paying their own bids roughly 80% of the time for Sponsored Products by 2024.
Amazon.com, Inc. (NASDAQ:AMZN) disputes the allegations, arguing that the FTC misunderstands how its advertising auctions work and that its pricing practices improve ad relevance and value for advertisers.
Photo by Bryan Angelo on Unsplash
The biggest positive for Amazon.com, Inc. (NASDAQ:AMZN) is that the lawsuit does not immediately undermine the underlying strength of its advertising business. Amazon generated about $68 billion in advertising revenue in 2025, making advertising an increasingly important and high-margin contributor to the company's overall profitability.
#amazon #amzn #allegations
According to the complaint, the practice affected more than one million brands and sellers and may have generated tens of billions of dollars in additional revenue for Amazon. The FTC also alleges that the pricing changes became increasingly aggressive, with advertisers paying their own bids roughly 80% of the time for Sponsored Products by 2024.
Amazon.com, Inc. (NASDAQ:AMZN) disputes the allegations, arguing that the FTC misunderstands how its advertising auctions work and that its pricing practices improve ad relevance and value for advertisers.
Photo by Bryan Angelo on Unsplash
The biggest positive for Amazon.com, Inc. (NASDAQ:AMZN) is that the lawsuit does not immediately undermine the underlying strength of its advertising business. Amazon generated about $68 billion in advertising revenue in 2025, making advertising an increasingly important and high-margin contributor to the company's overall profitability.
#amazon #amzn #allegations
10 days ago
Meet the 7 underrated QBs who could be college football's next Fernando Mendoza originally appeared on The Sporting News. Add The Sporting News as a Preferred Source by clicking here.
There might never be a better example of how drastically a quarterback class can change in a few short months than the 2025 college football season.
LaNorris Sellers, Cade Klubnik and Garrett Nussmeier were all considered legitimate first-round prospects and potential Heisman Trophy contenders. The name Fernando Mendoza was known by a much more limited number of fans, with the exception of those who stayed up deep into the night to watch him duel with Cam Ward at Cal.
The quarterbacks to watch this college football season are supposed to be Arch Manning, Dante Moore, CJ Carr, Julian Sayin, Trinidad Chambliss and Darian Mensah. It doesn't usually work out that way, though.
At least one quarterback without much name recognition in Week 1 is going to find his way into the thick of the Heisman Trophy race or the first round discussion, if not both. A rise like Mendoza's is tough to mirror, but there are a number of quarterbacks who have the talent to reach stardom in 2026.
#sporting
There might never be a better example of how drastically a quarterback class can change in a few short months than the 2025 college football season.
LaNorris Sellers, Cade Klubnik and Garrett Nussmeier were all considered legitimate first-round prospects and potential Heisman Trophy contenders. The name Fernando Mendoza was known by a much more limited number of fans, with the exception of those who stayed up deep into the night to watch him duel with Cam Ward at Cal.
The quarterbacks to watch this college football season are supposed to be Arch Manning, Dante Moore, CJ Carr, Julian Sayin, Trinidad Chambliss and Darian Mensah. It doesn't usually work out that way, though.
At least one quarterback without much name recognition in Week 1 is going to find his way into the thick of the Heisman Trophy race or the first round discussion, if not both. A rise like Mendoza's is tough to mirror, but there are a number of quarterbacks who have the talent to reach stardom in 2026.
#sporting
10 days ago
Micron's (MU) Q3 revenue beat estimates by 18%, and 16 strategic agreements lock in roughly $100 billion in guaranteed minimum revenue.
MU's 6x forward P/E looks strikingly cheap against NVDA's 44x trailing multiple, positioning it as the lower-valuation AI memory bet.
Insiders are net sellers at the highest rate since 2010, and $27 billion in FY26 capex raises cycle-peak spending flags.
Act now: the **** yst who called NVIDIA in 2010 just named his top 10 AI stocks — and Micron Technology didn't make the cut. Grab the names FREE today.
Memory stocks have quietly become one of the most powerful AI trades of the cycle, and no name captures it better than Micron Technology (NASDAQ:MU).
#revenue #cycle
MU's 6x forward P/E looks strikingly cheap against NVDA's 44x trailing multiple, positioning it as the lower-valuation AI memory bet.
Insiders are net sellers at the highest rate since 2010, and $27 billion in FY26 capex raises cycle-peak spending flags.
Act now: the **** yst who called NVIDIA in 2010 just named his top 10 AI stocks — and Micron Technology didn't make the cut. Grab the names FREE today.
Memory stocks have quietly become one of the most powerful AI trades of the cycle, and no name captures it better than Micron Technology (NASDAQ:MU).
#revenue #cycle
10 days ago
IPO Edge hosted a fireside chat on Aug. 26 at Nasdaq MarketSite with Brittany Kaiser, Chief Executive Officer of Alpha Compute Corp. (Nasdaq: ALP). The in-person interview was joined by Editor-in-Chief John Jannarone and they discussed how the company is building the infrastructure AI runs on with a focus on data privacy, and how its vertically integrated business model is boosting compute revenue.
About Brittany Kaiser
Brittany Kaiser is Chief Executive Officer of Alpha Compute Corp. (Nasdaq: ALP), where she leads strategy in confidential computing, data sovereignty, and AI infrastructure. A globally recognized authority on data rights, digital **** ets, and AI governance, she became a leading voice in the modern privacy movement after serving as a whistleblower in the Cambridge **** ytica scandal.
Kaiser is the author of the international bestseller Targeted and the principal subject of the Emmy- and BAFTA-nominated Netflix documentary The Great Hack. She has advised U.S. congressional committees, governments, and regulators on data ownership, digital **** et policy, and responsible AI, and co-authored legislation shaping the digital economy. A serial entrepreneur and advocate, she is also Co-Founder and President of the Own Your Data Foundation and a sought-after keynote speaker worldwide.
About Alpha Compute Corp (Nasdaq: ALP)
Alpha Compute Corp. (Nasdaq: ALP) is a vertically integrated AI infrastructure company specializing in GPU-as-a-service and AI Confidential Compute. Alpha Compute's mission is to support clients, subsidiaries, and partners across critical sectors including: finance, defense, intelligence, and media with the essential framework for any organization requiring secure, confidential computing environments. For more information, please visit: https://www.alphacompute.a...
Alpha Compute Corp is domiciled in the British Virgin Islands with offices in New York, Los Angeles, Miami, Amsterdam and Toronto. Alpha Compute is a founding partner of the Right2Compute Coalition; more information is available at www.right2compute.com.
#compute #alpha #chief #infrastructure
About Brittany Kaiser
Brittany Kaiser is Chief Executive Officer of Alpha Compute Corp. (Nasdaq: ALP), where she leads strategy in confidential computing, data sovereignty, and AI infrastructure. A globally recognized authority on data rights, digital **** ets, and AI governance, she became a leading voice in the modern privacy movement after serving as a whistleblower in the Cambridge **** ytica scandal.
Kaiser is the author of the international bestseller Targeted and the principal subject of the Emmy- and BAFTA-nominated Netflix documentary The Great Hack. She has advised U.S. congressional committees, governments, and regulators on data ownership, digital **** et policy, and responsible AI, and co-authored legislation shaping the digital economy. A serial entrepreneur and advocate, she is also Co-Founder and President of the Own Your Data Foundation and a sought-after keynote speaker worldwide.
About Alpha Compute Corp (Nasdaq: ALP)
Alpha Compute Corp. (Nasdaq: ALP) is a vertically integrated AI infrastructure company specializing in GPU-as-a-service and AI Confidential Compute. Alpha Compute's mission is to support clients, subsidiaries, and partners across critical sectors including: finance, defense, intelligence, and media with the essential framework for any organization requiring secure, confidential computing environments. For more information, please visit: https://www.alphacompute.a...
Alpha Compute Corp is domiciled in the British Virgin Islands with offices in New York, Los Angeles, Miami, Amsterdam and Toronto. Alpha Compute is a founding partner of the Right2Compute Coalition; more information is available at www.right2compute.com.
#compute #alpha #chief #infrastructure
10 days ago
Berkshire Hathaway (NYSE: BRKA)(NYSE: BRKB) bought back $4.5 billion in stock in the second quarter, its first major buyback activity since early 2024. While other companies buy back billions of dollars in stock, Berkshire's buyback program is a unique one.
Specifically, Berkshire buys back stock only when its leaders believe it trades at a considerable discount to intrinsic value. This lets investors use Berkshire's buyback as a signal that the stock might be cheap.
Missed Nvidia in 2009? This Rare Signal Is Flashing Again. In 2009, a "Double Down" signal flashed for a little-known chipmaker called Nvidia. For the first time in years, that same "Total Conviction" signal is flashing for a company 1/100th the size of Nvidia. Continue »
Of course, there's more to the story. For one thing, Berkshire started the second quarter with a record high $397.4 billion in cash and Treasuries, and new CEO Abel has been eager to find ways to put it to work.
Also, the second quarter's buyback could be an especially strong signal that Abel believes the stock is cheap right now. Not only is $4.5 billion the most Berkshire Hathaway has spent on buybacks in a single quarter since 2021, but Berkshire's buybacks in recent years have generally occurred while Berkshire was a net seller of stocks.
#second
Specifically, Berkshire buys back stock only when its leaders believe it trades at a considerable discount to intrinsic value. This lets investors use Berkshire's buyback as a signal that the stock might be cheap.
Missed Nvidia in 2009? This Rare Signal Is Flashing Again. In 2009, a "Double Down" signal flashed for a little-known chipmaker called Nvidia. For the first time in years, that same "Total Conviction" signal is flashing for a company 1/100th the size of Nvidia. Continue »
Of course, there's more to the story. For one thing, Berkshire started the second quarter with a record high $397.4 billion in cash and Treasuries, and new CEO Abel has been eager to find ways to put it to work.
Also, the second quarter's buyback could be an especially strong signal that Abel believes the stock is cheap right now. Not only is $4.5 billion the most Berkshire Hathaway has spent on buybacks in a single quarter since 2021, but Berkshire's buybacks in recent years have generally occurred while Berkshire was a net seller of stocks.
#second
11 days ago
MD Sass, a boutique ****** et management firm, published its second-quarter investor update for its flagship, the "MD Sass Concentrated Value Strategy." The letter can be downloaded here. In the first half of 2026, AI infrastructure stocks led the market, with the Russell 1000 Value increasing by 16.3%, outpacing the S&P 500 (10.2%) and Russell 1000 Growth (5.3%). This growth was fueled by semiconductor, memory, and hardware companies benefiting from AI development, even though they are considered cyclical. These sectors, representing only 7.7% of the Russell 1000 Value at the start of the year, contributed nearly 70% of its returns. The portfolio gained 10.0% in the second quarter, net of fees, compared to 13.9% for the Russell 1000 Value Index. Year-to-date, the strategy returned 6.6%, net of fees, versus 16.3% for the Index. The portfolio faced challenges due to limited exposure to companies with the greatest upside from AI infrastructure investments. It also lacked exposure to the Energy sector, which returned about 20% in the first half amid geopolitical tensions with Iran that increased commodity prices, affecting performance. The firm recognizes the importance of adapting its strategies while maintaining core investment principles as it explores future opportunities in emerging technological themes. Also, check the fund's top five holdings to see its best picks in 2026.
In its second-quarter 2026 investor letter, MD Sass Concentrated Value Strategy highlighted TD SYNNEX Corporation (NYSE:SNX) as a new portfolio holding. TD SYNNEX Corporation (NYSE:SNX) is a leading distributor and solutions aggregator for the information technology (IT) ecosystem. On August 28, 2026, TD SYNNEX Corporation (NYSE:SNX) closed at $253.97 per share. Over the past month, TD SYNNEX Corporation (NYSE:SNX) returned -1.12%, while its shares have declined 69.50% in the last 52 weeks. TD SYNNEX Corporation (NYSE:SNX) has a market capitalization of $20.31 billion.
MD Sass Concentrated Value Strategy stated the following regarding TD SYNNEX Corporation (NYSE:SNX) in its Q2 2026 investor letter:
"During the quarter, we initiated a position in TD SYNNEX Corporation (NYSE:SNX), one of the world's largest IT distributors and a critical intermediary between technology vendors and more than 150,000 customers across over 100 countries. Its core Distribution business aggregates hardware, software, cloud products, and services while providing inventory, financing, configuration, and technical support to resellers and systems integrators. Distribution is a low-margin business, but scale matters, and SNX is increasingly benefiting as major vendors consolidate their channel relationships around a smaller number of global partners.
The crux of our thesis, however, is Hyve Solutions, a hidden growth engine that we believe the market continues to value as part of a traditional IT distributor. Hyve, a wholly owned subsidiary of SNX, designs, manufactures, integrates, and manages th
In its second-quarter 2026 investor letter, MD Sass Concentrated Value Strategy highlighted TD SYNNEX Corporation (NYSE:SNX) as a new portfolio holding. TD SYNNEX Corporation (NYSE:SNX) is a leading distributor and solutions aggregator for the information technology (IT) ecosystem. On August 28, 2026, TD SYNNEX Corporation (NYSE:SNX) closed at $253.97 per share. Over the past month, TD SYNNEX Corporation (NYSE:SNX) returned -1.12%, while its shares have declined 69.50% in the last 52 weeks. TD SYNNEX Corporation (NYSE:SNX) has a market capitalization of $20.31 billion.
MD Sass Concentrated Value Strategy stated the following regarding TD SYNNEX Corporation (NYSE:SNX) in its Q2 2026 investor letter:
"During the quarter, we initiated a position in TD SYNNEX Corporation (NYSE:SNX), one of the world's largest IT distributors and a critical intermediary between technology vendors and more than 150,000 customers across over 100 countries. Its core Distribution business aggregates hardware, software, cloud products, and services while providing inventory, financing, configuration, and technical support to resellers and systems integrators. Distribution is a low-margin business, but scale matters, and SNX is increasingly benefiting as major vendors consolidate their channel relationships around a smaller number of global partners.
The crux of our thesis, however, is Hyve Solutions, a hidden growth engine that we believe the market continues to value as part of a traditional IT distributor. Hyve, a wholly owned subsidiary of SNX, designs, manufactures, integrates, and manages th
11 days ago
ShipStation, a provider of multicarrier parcel shipping software, is offering e-commerce sellers the ability to also select and coordinate with less-than-truckload operators at pre-negotiated rates in one integrated platform, bringing to life promised benefits from ownership's recent acquisition of freight brokerage Worldwide Express Group.
Few, if any, software-as-a-service companies that connect small-and-midsize merchants with parcel carriers offer a pallet-shipping solution.
"Most of those small companies don't have enough volumes to do full truckload so their first need after parcel shipping tends to be LTL, which creates this natural linkage between LTL freight brokerage and parcel," said Chris Wofford, the founder of Wofford Advisors LLC, a strategic advisory firm for the logistics sector.
In early June, private equity firm Thoma Bravo acquired WWEX Group and merged it with portfolio company Auctane, which provides shipping and fulfillment technology through brands like ShipStation, Stamps.com, Metapack and Packlink. The combined valuation of the companies is $12 billion.
WWEX Group companies include Worldwide Express, GlobalTranz, Unishippers, JEAR Logistics and BLX Logistics.
#parcel #Companies #wwex
Few, if any, software-as-a-service companies that connect small-and-midsize merchants with parcel carriers offer a pallet-shipping solution.
"Most of those small companies don't have enough volumes to do full truckload so their first need after parcel shipping tends to be LTL, which creates this natural linkage between LTL freight brokerage and parcel," said Chris Wofford, the founder of Wofford Advisors LLC, a strategic advisory firm for the logistics sector.
In early June, private equity firm Thoma Bravo acquired WWEX Group and merged it with portfolio company Auctane, which provides shipping and fulfillment technology through brands like ShipStation, Stamps.com, Metapack and Packlink. The combined valuation of the companies is $12 billion.
WWEX Group companies include Worldwide Express, GlobalTranz, Unishippers, JEAR Logistics and BLX Logistics.
#parcel #Companies #wwex
13 days ago
Revolution Medicines, Inc. (NASDAQ:RVMD) touched an all-time high above $224 on August 27, 2026, following FDA approval of Rasonque (daraxonrasib) – the first broad RAS-targeted therapy cleared for metastatic pancreatic cancer. Creating a milestone, the approval came roughly five weeks after filing under the agency's national priority voucher. The pivotal RASolute 302 trial nearly doubled median overall survival, to 13.2 months from 6.7 on chemotherapy. While the clinical benefit is substantial, a $47 billion valuation suggests the market had already priced in this success.
RVMD carries essentially no product revenue yet. Its price rests entirely on the future. Evercore ISI has raised the next-year sales estimate for Rasonque to ~$2.4 billion. Additionally, the $47 billion valuation discounts much of a long-term pancreatic opportunity which the Evercore **** yst estimates Rasonque could generate about $15.1 billion in pancreatic-cancer sales by 2034. However, a few details complicate this math. First, the approved label applies strictly to second-line or multiagent-ineligible patients. The front-line indication represents the larger market opportunity but remains pending, meaning a notable portion of the TAM is not yet accessible. Second, RVMD's current valuation also sits well above the $28 billion–$32 billion takeover valuation reportedly discussed with Merck earlier this year. Bulls argue lung and colorectal trials justify the $47 billion beyond pancreatic cancer, though that pipeline potential remains unproven.
That matters because Revolution Medicines must now execute its first commercial launch independently in one of oncology's most challenging indications characterized by short survival, high patient frailty, and a U.S. list price of $39,800 for a 30-day supply. Commercialization will require heavy spending. The second-quarter net loss widened to $644 million, and full-year operating expense guidance increased to between $2.1 and $2.2 billion. While a $3.9 billion cash balance and up to $1.5 billion in committed royalty financing fund the launch, operational execution remains the primary risk.
Insiders were net sellers of roughly $21.5 million over the past 90 days with zero buying. Hedge fund data on the stock is flat. As per the Insider Monkey database, 105 funds held RVMD in the second quarter of 2026, modestly down from 106 in the first, indicating strong conviction among institutional investors. Short interest sits near 6% of float, representing a modest level of bets against the stock.
#first
RVMD carries essentially no product revenue yet. Its price rests entirely on the future. Evercore ISI has raised the next-year sales estimate for Rasonque to ~$2.4 billion. Additionally, the $47 billion valuation discounts much of a long-term pancreatic opportunity which the Evercore **** yst estimates Rasonque could generate about $15.1 billion in pancreatic-cancer sales by 2034. However, a few details complicate this math. First, the approved label applies strictly to second-line or multiagent-ineligible patients. The front-line indication represents the larger market opportunity but remains pending, meaning a notable portion of the TAM is not yet accessible. Second, RVMD's current valuation also sits well above the $28 billion–$32 billion takeover valuation reportedly discussed with Merck earlier this year. Bulls argue lung and colorectal trials justify the $47 billion beyond pancreatic cancer, though that pipeline potential remains unproven.
That matters because Revolution Medicines must now execute its first commercial launch independently in one of oncology's most challenging indications characterized by short survival, high patient frailty, and a U.S. list price of $39,800 for a 30-day supply. Commercialization will require heavy spending. The second-quarter net loss widened to $644 million, and full-year operating expense guidance increased to between $2.1 and $2.2 billion. While a $3.9 billion cash balance and up to $1.5 billion in committed royalty financing fund the launch, operational execution remains the primary risk.
Insiders were net sellers of roughly $21.5 million over the past 90 days with zero buying. Hedge fund data on the stock is flat. As per the Insider Monkey database, 105 funds held RVMD in the second quarter of 2026, modestly down from 106 in the first, indicating strong conviction among institutional investors. Short interest sits near 6% of float, representing a modest level of bets against the stock.
#first
14 days ago
Expion360 Inc. (NASDAQ:XPON) shares closed at $6.20 on August 24, up 80.5% following the company's oil-and-gas acquisition and financing disclosures. The transactions reposition the lithium-battery specialist as a broader energy company. The company also announced a corporate name change to Expion Energy, Inc. as part of the expansion.
Expion360 Inc. (NASDAQ:XPON) paid an adjusted $3.425 million in cash for a company holding an Eastern Louisiana exploration prospect. The acquired ****** ets include approximately 3,000 net leasehold acres, an existing wellbore, mineral-title research covering approximately 13,000 net acres, and related intellectual property. The announcement did not include current production or an estimate of proved reserves.
The company financed the move through $9 million of convertible debentures, generating approximately $8.2 million of net proceeds after fees and expenses.
Expion360 Inc. (NASDAQ:XPON) acquired a defined exploration target rather than starting its acreage and geological work from scratch. The company plans to expand the leasehold and use commercially reasonable efforts to initiate a mandatory well operation involving a lateral wellbore of at least 4,000 feet by February 15, 2027, subject to specified exceptions.
The company expects to retain an approximately 75% net revenue interest after overriding royalty interests. New CEO Kevin Sellers also brings experience in upstream and midstream transactions, addressing part of the expertise gap created by the move beyond battery storage.
#approximately #energy #part
Expion360 Inc. (NASDAQ:XPON) paid an adjusted $3.425 million in cash for a company holding an Eastern Louisiana exploration prospect. The acquired ****** ets include approximately 3,000 net leasehold acres, an existing wellbore, mineral-title research covering approximately 13,000 net acres, and related intellectual property. The announcement did not include current production or an estimate of proved reserves.
The company financed the move through $9 million of convertible debentures, generating approximately $8.2 million of net proceeds after fees and expenses.
Expion360 Inc. (NASDAQ:XPON) acquired a defined exploration target rather than starting its acreage and geological work from scratch. The company plans to expand the leasehold and use commercially reasonable efforts to initiate a mandatory well operation involving a lateral wellbore of at least 4,000 feet by February 15, 2027, subject to specified exceptions.
The company expects to retain an approximately 75% net revenue interest after overriding royalty interests. New CEO Kevin Sellers also brings experience in upstream and midstream transactions, addressing part of the expertise gap created by the move beyond battery storage.
#approximately #energy #part
15 days ago
GM Nolan Teasley is probably going to have some opportunity to pull off a trade or two over these next few days. At the very least, the Vikings' cap ***** e and draft picks will allow for an addition(s) if a compelling trade possibility emerges.
Teams around the NFL are moving into a tough weekend. What has been a 90-player roster is going to get shrunk down to 53 players. As Kevin Patra points out, there are going to be close to 1,200 players who are told to pack their bags. Pretty reasonably, teams will seek to add value out of player departures when possible, trying to pull off a trade before needing to accept a cut. Could the Vikings actually accommodate some swaps?
At least a few things are needed to pull off a trade.
Most obvious, perhaps, is that there needs to be at least a pair of teams willing to pull off a deal. During cut weekend, there's going to be no shortage of sellers for the Vikings to consider. Every single team has dozens of players who are getting shown the door; extracting value by recouping a pick(s) for one of these players is a better outcome than moving on for no value coming back. So, that end of things shouldn't be an issue.
Aug 22, 2026; Minneapolis, Minnesota, USA; Minnesota Vikings linebacker Ivan Pace Jr. (0) prays before the game against the Baltimore Ravens at U.S. Bank Stadium. Mandatory Credit: Matt Krohn-Imagn Images
#moving
Teams around the NFL are moving into a tough weekend. What has been a 90-player roster is going to get shrunk down to 53 players. As Kevin Patra points out, there are going to be close to 1,200 players who are told to pack their bags. Pretty reasonably, teams will seek to add value out of player departures when possible, trying to pull off a trade before needing to accept a cut. Could the Vikings actually accommodate some swaps?
At least a few things are needed to pull off a trade.
Most obvious, perhaps, is that there needs to be at least a pair of teams willing to pull off a deal. During cut weekend, there's going to be no shortage of sellers for the Vikings to consider. Every single team has dozens of players who are getting shown the door; extracting value by recouping a pick(s) for one of these players is a better outcome than moving on for no value coming back. So, that end of things shouldn't be an issue.
Aug 22, 2026; Minneapolis, Minnesota, USA; Minnesota Vikings linebacker Ivan Pace Jr. (0) prays before the game against the Baltimore Ravens at U.S. Bank Stadium. Mandatory Credit: Matt Krohn-Imagn Images
#moving
